Výsledky vyhledávání - "Peter Petera"

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

Publikováno v: Annals of the Rheumatic Diseases. 69:61-64

Objective:To update the follow-up of the Euro-Lupus Nephritis Trial (ELNT), a randomised prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) cyclophosphamide (CY) followed by azathioprine (AZA) as treatment for proliferative

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::483b7fe271791238f2a90b481df874bc
https://doi.org/10.1136/ard.2008.102533

Zobrazit plný text záznamu

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial

Publikováno v: Arthritis & Rheumatism. 50:3934-3940

OBJECTIVE: In the Euro-Lupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were randomly assigned to a high-dose intravenous cyclophosphamide (IV CYC) regimen (6 monthly pulses and 2 quarterly pulses with escalating doses) or a low-dose IV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::794e1ff7b1f64d1631f641cb8634838b
https://doi.org/10.1002/art.20666

Zobrazit plný text záznamu

Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

Publikováno v: Arthritis & Rheumatism. 46:2121-2131

OBJECTIVE: Glomerulonephritis is a severe manifestation of systemic lupus erythematosus (SLE) that is usually treated with an extended course of intravenous (IV) cyclophosphamide (CYC). Given the side effects of this regimen, we evaluated the efficac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::63fd968d611e3e920f57cd24ff5b9b50
https://doi.org/10.1002/art.10461

Zobrazit plný text záznamu

The concurrence of rheumatoid arthritis and limited systemic sclerosis: Clinical and serologic characteristics of an overlap syndrome

Autor: Günter Steiner, Karl Skriner, Wolfgang Hassfeld, Peter Petera, Josef S. Smolen, Christof Zimmermann

Publikováno v: Arthritis & Rheumatism. 41:1938-1945

Objective The characteristics of 3 patients with longstanding rheumatoid arthritis (RA) and consecutive evolution of limited cutaneous systemic sclerosis (lcSSc) were evaluated and compared with those of patients with lcSSc alone (n = 20) or with RA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::713fb8e6a91325460a1343c20292d16c
https://doi.org/10.1002/1529-0131(199811)41:11<1938::aid-art7>3.0.co

Zobrazit plný text záznamu

Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis

Autor: Stephen Gadd, Thomas Felzmann, Peter Petera, Josef S. Smolen, Otto Majdic, Dieter Maurer, Walter Knapp

Publikováno v: Journal of clinical immunology. 11(4)

In this study we report the expression pattern of 13 different function-associated surface molecules on synovial fluid and peripheral blood granulocytes from rheumatoid and reactive arthritis patients. We found increased expression of the complement

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc8c068c2470d656fe25ed4d6f1dc364
https://pubmed.ncbi.nlm.nih.gov/1918267

Zobrazit plný text záznamu

Akademický článek

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial.

Publikováno v: Arthritis & Rheumatism; Dec2004, Vol. 50 Issue 12, p3934-3940, 7p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání